CorDynamics Announces Trade Show Events for the Coming New Year

Chicago, IL (December 2011) - CorDynamics set its 2012 trade show calendar in anticipation of the New Year.

For the first time, the CorDynamics team will exhibit at the Experimental Biology meeting in San Diego April 21-25.

"As CorDynamics continues to grow the cardiovascular drug discovery side of our business, we look forward to attending EB 2012 and showcasing our capabilities in this arena," says Dr. Michael Gralinski, CorDynamics CEO.

CorDynamics will also attend three additional events in 2012:

  • Society of Toxicology 51st Annual Meeting
    San Francisco, March 11-15
  • 2012 Safety Pharmacology Society Annual Meeting
    Phoenix, October 1-4
  • American College of Toxicology 33rd Annual Meeting
    Orlando, November 4-7

"Providing customer service and expert advice is what I believe we do best," says Dr. Gralinski. "These meetings give us a unique opportunity to connect with many of our clients, colleagues and industry partners over the course of a few informative days."

CorDynamics, Inc. is a comprehensive contract research organization and consulting group focused on examining the cardiovascular effects of emerging drug candidates. The company provides support with discovery and preclinical safety pharmacology studies along with lead optimization screening and consulting for more than 200 biopharmaceutical clients worldwide.

To learn more about CorDynamics, please visit our website at cordynamics.com or contact Dr. Gralinski at .

Contact:
Michael R. Gralinski, Ph.D., CorDynamics CEO